Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
TriSalus Life Sciences, Inc.TriSalus Life Sciences Reports 52.3% Revenue Growth but Incurred $9M Net Loss in Q2 2025
Slide Insurance Holdings, Inc.Slide Insurance Holdings Reports 25.1% Revenue Growth to $261.6 Million in Q2 2025
SKYX Platforms Corp.SKYX Platforms Reports 8% Revenue Growth to $23.1 Million in Q2 2025
EXOZYMES INC.eXoZymes Reports $4.22 Million Net Loss and Significant Financial Challenges
PARKERVISION INCParkerVision Reports $5.4 Million Net Loss and Increased Operating Expenses for First Half of 2025
FATE THERAPEUTICS INCFate Therapeutics Reports Decrease in Collaboration Revenue and Net Loss for Q2 2025
374Water Inc.374Water Inc. Reports 223% Revenue Increase but Faces Significant Net Loss in Q2 2025
vTv Therapeutics Inc.vTv Therapeutics Reports $6M Net Loss and Zero Revenue for Q2 2025
Metagenomi Therapeutics, Inc.Metagenomi Reports Significant Revenue Decline and Increased Net Loss in Q2 2025
Caribou Biosciences, Inc.Caribou Biosciences Reports $54.1 Million Net Loss in Q2 2025
Editas Medicine, Inc.Editas Medicine Reports Q2 2025 Financial Results with Reduced Net Loss and Increased R&D Revenues
Maze Therapeutics, Inc.Maze Therapeutics Reports No Revenue and $33.7 Million Net Loss for Q2 2025
ALX ONCOLOGY HOLDINGS INCALX Oncology Reports $25.9 Million Net Loss in Q2 2025, Focuses on Clinical Pipeline
ANAVEX LIFE SCIENCES CORP.Anavex Life Sciences Reports $13.2 Million Net Loss in Q3 Fiscal 2025
IZEA Worldwide, Inc.IZEA Worldwide Reports $1.2 Million Net Income in Q2 2025, Revenue Slightly Up
GLADSTONE INVESTMENT CORPORATION\DEGladstone Investment Corporation Reports Q2 2025 Financial Results with Increased Investment Income
Anterix Inc.Anterix Inc. Reports $25.2 Million Net Income Turnaround for Q2 2025
ARK RESTAURANTS CORPArk Restaurants Corp. Reports Revenue Decline and Operating Loss Amid Lease Disputes
Horizon Kinetics Holding CorpHorizon Kinetics Reports 73% Revenue Growth but $10.5 Million Net Loss in Q2 2025
AN2 Therapeutics, Inc.AN2 Therapeutics Reports 55% Decrease in Net Losses for Q2 2025
Silexion Therapeutics CorpSilexion Therapeutics Reports $4.2 Million Net Loss for First Half of 2025
VirnetX Holding CorpVirnetX Reports Revenue Increase to $48,000 but Posts $3.6 Million Net Loss in Q2 2025
Hall of Fame Resort & Entertainment CoHall of Fame Resort & Entertainment Company Reports $12.2 Million Net Loss for Q2 2025
Mobile Infrastructure CorpMobile Infrastructure Corporation Reports Revenue Decline and Increased Net Losses in Q2 2025
Stark Novus Financial Inc.Nu Ride Inc. Reports Q2 2025 Financial Results with Net Income of $742,000